IPO
Invea Therapeutics, Inc
Withdrawn on Mar 6, 2026. Filed with the SEC to go public on Dec 15, 2025.
Terms
| Price range | US$10.00 to US$12.00 a share | |
| Shares offered | 3,200,000 shares of common stock | |
| Offering size | US$32 million to US$38.4 million | Shares offered times the price range, worked out by 6ix |
| Underwriters' option | Up to 480,000 more shares | |
| Listing | INAI on the Nasdaq Capital Market | Has applied to list |
| Underwriter | ThinkEquity |
From the cover of the amended prospectus (S-1/A) filed Jan 27, 2026
Steps
| Draft sent to the SEC in confidence | Mar 10, 2025 |
| Filed publicly | Dec 15, 2025 |
| Amended 3 times | Newest Jan 27, 2026 |
| Filing withdrawn | Mar 6, 2026 |
Filings
- Mar 6, 2026 RW · Request to withdraw a registration
- Jan 30, 2026 EFFECT · Notice that a registration is effective
- Jan 27, 2026 S-1/A · Registration statement, amended
- Jan 23, 2026 S-1/A · Registration statement, amended
- Jan 9, 2026 FWP · Free writing prospectus
- Jan 7, 2026 S-1/A · Registration statement, amended
- Dec 15, 2025 S-1 · Registration statement
- Nov 13, 2025 DRS/A · Draft registration statement, amended
- Mar 10, 2025 DRS · Draft registration statement